Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

87 results
Display

Expanding the therapeutic landscape: ezetimibe as non-statin therapy for dyslipidemia

Lee J, Lee SH

Dyslipidemia is a significant risk factor for atherosclerotic cardiovascular disease (ASCVD), and statins are the primary therapeutic options for reducing low-density lipoprotein cholesterol (LDL-C) levels. However, it can be challenging...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Lipid variability in patients with diabetes mellitus

Lee J, Lee SH

Diabetic dyslipidemia is characterized by hypertriglyceridemia, low high-density lipoprotein cholesterol (HDL-C), elevated low-density lipoprotein cholesterol (LDL-C), and the predominance of small dense LDL particles caused by insulin resistance in patients...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Diabetes and Dietary Fats

Cho JW

Fats are important nutrients that supply energy and help to regulate the processes of the human body. The proportion of fat in the energy intake of Koreans, as well as...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
2023 Clinical Practice Guidelines for Diabetes: Management of Cardiovascular Risk Factors

Yang YS

To prevent cardiovascular disease (CVD), which is one of the ultimate goals in the management of patients with diabetes, it is important to control not only hyperglycemia, but also modifiable...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Management of Dyslipidemia in Patients with Diabetes Mellitus

Lee KA

Most patients with diabetes mellitus (DM) have dyslipidemia, which is characterized by increased triglycerides, decreased high-density lipoprotein cholesterol, and increased small dense low-density lipoprotein cholesterol (LDL-C). Dyslipidemia is an important...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Public Awareness of Dyslipidemia Among the Korean Population: A Survey Study

Bae JH, Jin ES, Kim SE, Kang S, Lee JY, Kim M, Jin HY, Shin MJ, Jeong IK, the Committee of Public Relation of the Korean Society of Lipid and Atherosclerosis

Objective: We aimed to assess the level of public awareness regarding dyslipidemia and its management among the Korean population. Methods: We conducted a web- or mobile-based survey study targeting the general...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Dyslipidemia Fact Sheet in South Korea, 2022

Jin ES, Shim JS, Kim SE, Bae JH, Kang S, Won JC, Shin MJ, Jin HY, Moon J, Lee H, Kim HC, Jeong IK, on Behalf of the Committee of Public Relation of the Korean Society of Lipid and Atherosclerosis

Background: This study aimed to investigate the prevalence and status of dyslipidemia management among South Korean adults, as performed by the Korean Society of Lipid and Atherosclerosis under the name...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Dyslipidemia Fact Sheet in South Korea, 2022

Jin ES, Shim JS, Kim SE, Bae JH, Kang S, Won JC, Shin MJ, Jin HY, Moon J, Lee H, Kim HC, Jeong IK, on behalf of the Committee of Public Relation of the Korean Society of Lipid and Atherosclerosis

Objective: This study aimed to investigate the prevalence and status of dyslipidemia management among South Korean adults, as performed by the Korean Society of Lipid and Atherosclerosis under the name...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Dyslipidemia in Patients with Chronic Kidney Disease: An Updated Overview

Suh SH, Kim SW

Dyslipidemia is a potentially modifiable cardiovascular risk factor. Whereas the recommendations for the treatment target of dyslipidemia in the general population are being more and more rigorous, the 2013 Kidney...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The effect of hypothalamic involvement and growth hormone treatment on cardiovascular risk factors during the transition period in patients with childhood-onset craniopharyngioma

Park SH, Lee YJ, Cheon JE, Shin CH, Jung HW, Lee YA

Purpose: Hypothalamic damage may increase the risk of adulthood obesity and cardiovascular disease in patients with craniopharyngioma. We evaluated the effects of hypothalamic involvement (HI) and growth hormone (GH) discontinuation...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Cardiovascular Outcomes according to Comorbidities and Low-Density Lipoprotein Cholesterol in Korean People with Type 2 Diabetes Mellitus

Moon MK, Noh J, Rhee EJ, Park SH, Kim HC, Kim BJ, Kim HJ, Choi S, Na JO, Hyun YY, Kim BJ, Han KD, Jeong IK, on Behalf of the Committee of Practice Guideline of Korean Lipid and Atheroscelerosis

Background: There are no clear data to support the cardiovascular (CV) risk categories and low-density lipoprotein cholesterol (LDL-C) treatment goals in Korean people with type 2 diabetes mellitus (T2DM). We...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Lipid Management in Korean People with Type 2 Diabetes Mellitus: Korean Diabetes Association and Korean Society of Lipid and Atherosclerosis Consensus Statement

Yang YS, Kim HL, Kim SH, Moon MK, on Behalf of Committee of Clinical Practice Guideline, Korean Diabetes Association and Clinical Practice Guideline Committee, Korean Society of Lipid and Atherosclerosis

Dyslipidemia in patients with diabetes is an important treatment target as a modifiable risk factor for cardiovascular disease (CVD). Although the primary treatment goal for dyslipidemia is to control low-density...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Lipid Management in Korean People With Type 2 Diabetes Mellitus: Korean Diabetes Association and Korean Society of Lipid and Atherosclerosis Consensus Statement

Yang YS, Kim HL, Kim SH, Moon MK, on behalf of Committee of Clinical Practice Guideline, Korean Diabetes Association and Clinical Practice Guideline Committee, Korean Society of Lipid and Atherosclerosis

Dyslipidemia in patients with diabetes is an important treatment target as a modifiable risk factor for cardiovascular disease (CVD). Although the primary treatment goal for dyslipidemia is to control low-density...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Impact of diabetes, obesity, and dyslipidemia on the risk of hepatocellular carcinoma in patients with chronic liver diseases

Shin HS, Jun BG, Yi SW

Despite the increasing prevalence of metabolic disorders, the potential effects of metabolic factors on hepatocellular carcinoma (HCC) development in individuals with chronic liver diseases (CLDs) are not well understood. For...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Management of Dyslipidemia after Stroke

Chang Yk, Song TJ

Dyslipidemia is a major risk factor for stroke, following hypertension, diabetes, and smoking. Treatment of dyslipidemia is important for the prevention and treatment of various vascular diseases, including stroke, coronary...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Screening and Management for Dyslipidemia in Korean Children and Adolescents

Yoon JS, Hwang IT

Cardiovascular disease (CVD) is the most common cause of death worldwide, and dyslipidemia is a major risk factor. Atherosclerosis can begin in childhood and continue into adulthood, thereby contributing to...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Effect of the addition of thiazolidinedione to sodium-glucose cotransporter 2 inhibitor therapy on lipid levels in type 2 diabetes mellitus: a retrospective study using Korean National Health Insurance Service data

Park T, Han K, Shin D, Park J

Background: Dyslipidemia is common in patients with type 2 diabetes mellitus (T2D) and contributes to an increased risk of cardiovascular disease. Previous studies have shown that treatment with thiazolidinediones (TZDs)...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
New, Novel Lipid-Lowering Agents for Reducing Cardiovascular Risk: Beyond Statins

Kim K, Ginsberg HN, Choi SH

Statins are the cornerstone of the prevention and treatment of atherosclerotic cardiovascular disease (ASCVD). However, even under optimal statin therapy, a significant residual ASCVD risk remains. Therefore, there has been...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Atherogenic Index of Plasma Predicts Early Recurrent Ischemic Lesion in Acute Ischemic Stroke

Nam KW, Kwon HM, Lee YS

Background: Atherogenic index of plasma (AIP) is an index representing the lipid profile of atherogenic dyslipidemia and has been shown to be associated with various atherosclerosis, metabolic diseases, and cardiovascular...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Current Status of Low-Density Lipoprotein Cholesterol Target Achievement in Patients with Type 2 Diabetes Mellitus in Korea Compared with Recent Guidelines

Yun SJ, Jeong IK, Cha JH, Lee J, Cho HC, Choi SH, Chun S, Jeon HJ, Kang HC, Kim SS, Ko SH, Koh G, Kwon SK, Lee JH, Moon MK, Noh J, Park CY, Kim S

Background: We evaluated the achievement of low-density lipoprotein cholesterol (LDL-C) targets in patients with type 2 diabetes mellitus (T2DM) according to up-to-date Korean Diabetes Association (KDA), European Society of Cardiology...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2023 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr